top of page

Recent Posts

Archive

Tags

Healthcare Contract Research Organization Market: The Role Of Technology In Research Efficiency

The global market for contract research organizations (CROs) was valued at a substantial USD 50.55 billion in 2023. This market is projected to experience significant growth, expanding at a Compound Annual Growth Rate (CAGR) of 7.0% from 2024 to 2030. Several key factors are driving this growth, including increased investment in research and development (R&D) programs, a growing preference for outsourcing activities to mitigate time and cost constraints, and the expiration of patents for blockbuster drugs.

 

CRO collaborations offer a range of advanced services, leading pharmaceutical and biopharmaceutical companies to increasingly favor outsourcing projects to CROs. This trend is further fueled by the mounting pressure on drug developers to adhere to rigorous clinical data management, regulatory environments, and stringent safety standards. Healthcare and pharmaceutical companies are actively outsourcing the production of medicines and their clinical trials. The privatization of clinical trials is also on the rise, contributing to a surge in outsourcing to developing countries.

 

Many CROs are strategically expanding their global research networks to enhance customer service. A notable example is MMS, a CRO specializing in data, which announced a collaboration with the Institute for Advanced Clinical Trials (I-ACT) in February 2023. This partnership aims to accelerate the development of critical therapeutics, such as medications, vaccines, and medical devices, specifically designed for pediatric use. As part of this commitment, MMS is sponsoring I-ACT's Spin Challenge, an initiative dedicated to raising funds to support and expedite clinical trials focused on children's healthcare.

 

Gather more insights about the market drivers, restrains and growth of the Healthcare Contract Research Organization Market

 

 

Regional Insights:

 

North America Healthcare Contract Research Organization Market Trends

 

The healthcare contract research organizations (CROs) market in North America is poised for steady growth, projected to expand at a 6.1% CAGR from 2023 to 2030. This growth is primarily attributed to the region's high volume of clinical trials, many of which are outsourced to CROs. Furthermore, robust government support for R&D initiatives, manifested through grants and funding to research institutions and companies, has significantly bolstered this market. For example, the U.S. health and medical research and development investment surged to USD 245.1 billion in 2020, marking an 11% increase from the previous year. The COVID-19 pandemic further accelerated this trend, with the Biomedical Advanced Research and Development Authority investing approximately USD 19,283 million in the development of COVID-19 vaccines.

 

U.S.

 

The United States emerged as a dominant player in the pharmaceutical market in 2023. This dominance is driven by several factors: significant investments in research and development, a thriving drug development sector, and a burgeoning biosimilars and biologics industry. The U.S. is renowned as a global pharmaceutical hub, with companies allocating a substantial portion of their revenue, approximately one-fifth, to research and development. However, the process of developing a new drug is both time-consuming and costly, often requiring a decade of dedicated effort and an investment of around USD 2.6 billion.

 

Asia Pacific Healthcare Contract Research Organization Market Trends

 

The Asia Pacific region has emerged as a dominant force in the healthcare contract research organization (CRO) market, claiming a significant 44.8% share of global revenue in 2023. This region is poised for substantial growth in the coming years, driven by several key factors. The high prevalence of chronic diseases, coupled with diverse populations, facilitates efficient patient recruitment and retention. Additionally, the alignment of regional regulations with international standards and supportive government initiatives, such as India's efforts to streamline drug approval processes, further accelerate market expansion.

 

Japan

Japan's healthcare CRO market is experiencing notable growth due to increased pharmaceutical innovation, rising healthcare expenditures, heightened awareness, and government support. Leading CROs like CMIC, EPS, IQVIA, Parexel, A2, and M3 are significantly contributing to this growth. Historically, Japanese pharmaceutical companies preferred an in-house approach for drug development, manufacturing, and sales. However, the evolving landscape has led to a growing reliance on CROs to enhance efficiency and expedite drug development timelines. 

 

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

 

 

 

Key Companies & Market Share Insights

 

The healthcare Contract Research Organization (CRO) market is a highly competitive space, driven by the increasing global demand for outsourcing clinical trial services. CRO healthcare companies are continuously vying for market share through strategic collaborations, acquisitions, and technological advancements to enhance their service offerings and expand their global reach. The market is characterized by a diverse range of CRO healthcare companies, varying in size and specialization. These companies cater to pharmaceutical, biotechnology, and medical device companies. CROs are focused on providing end-to-end solutions, and they are constantly innovating to streamline the drug development process, improve efficiency, and deliver high-quality outcomes. By doing so, they aim to position themselves competitively in the dynamic healthcare CRO landscape. 

 

Key Healthcare Contract Research Organization Companies

 

• ICON Plc

• Charles River Laboratories

• Syneos Health

• IQVIA Inc.

• GVK Biosciences Private Limited

• Laboratory Corporation of America Holdings

• Thermo Fisher Scientific Inc.

• Parexel International Corporation

• Medidata Solutions, Inc.

• Pharmaron GMBH

• SGS SA

• KCR S.A.

• CTI Clinical Trial & Consulting

• PSI

• Worldwide Clinical Trials

• Wuxi AppTec

• Advanced Clinical

• Pharm-Olam, LLC

• Caidy

 

Order a free sample PDF of the Healthcare Contract Research Organization Market Intelligence Study, published by Grand View Research.

Comments

bottom of page